SponsoredBlogPost_21

A Treatment Option for Patients with Myelodysplastic Syndromes

Brought to you by Bristol Myers Squibb Please join Bristol Myers Squibb for a product theater titled “A Treatment Option for Patients with Myelodysplastic Syndromes”.  This presentation will share information about a treatment option for myelodysplastic syndromes including an overview of MDS, ineffective erythropoiesis, the pivotal phase 3 trial design, efficacy, safety, dosing, and administration. […]

Read more
SponsoredBlogPost_21

Join Dr. Neil Love for Unique 11-Part NCPD Series Designed for Oncology Nurses

Brought to you by Research to Practice Join Dr Neil Love and 29 invited clinical investigators for this unique 11-part NCPD-accredited series designed specifically for oncology nurses. prior to these sessions, Dr Love will be sitting down with nurses in clinical practice from across the country as they present challenging cases from their practices. These recorded conversations will […]

Read more
SponsoredBlogPost_21

Managing Immune-related Adverse Events with Checkpoint Inhibitors

Brought to you by GSK Please join our presentation “Managing Immune-related Adverse Events with Checkpoint Inhibitors” on Tuesday, April 27th at 3:00 PM.  Immune checkpoint inhibitors play an important role in the treatment of many different cancers and have a distinct adverse event profile. Practical understanding of immune-related adverse events (irAEs) associated with checkpoint inhibitors is essential to […]

Read more
SponsoredBlogPost_21

SESSION PREVIEW: Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV): A Case-Based Presentation

Brought to you by Helsinn Therapeutics (U.S.), Inc. Helsinn is proud to offer a live, virtual symposium for attendees of 2021 Oncology Nursing Society (ONS) Annual Congress. Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV): A Case-Based Presentation will provide attendees with a better understanding of: A patient’s risk for CINV during highly and moderately emetic […]

Read more
SponsoredBlogPost_21

A Newly Approved Anti-CD38 Directed Combination for the Treatment of Multiple Myeloma Patients as Early as First Relapse

Brought to you by Sanofi-Genzyme Join Us!    Thursday, April 22  2:00-2:45 pm  A Newly Approved Anti-CD38 Directed Combination for the Treatment of Multiple Myeloma Patients as Early as First Relapse  Speaker:  Laura Mulka, MSN, APRN-BC, AOCN, ACHPN  Presentation Overview  Review management considerations for relapsed or refractory multiple myeloma (RRMM)  Examine a hypothetical case study of a patient with RRMM  Gain in-depth knowledge on […]

Read more
SponsoredBlogPost_21

BD Empowers Nurses and Patients with Port Education Program

Brought to you by BD BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. We are proud to share the PortReadyTM Program with the oncology community because we believe educating and empowering patients is an important component of delivering care. The PortReadyTM Program is […]

Read more
SponsoredBlogPost_21

Clinical management and dose modifications with an immunomodulatory treatment in relapsed/refractory multiple myeloma

Brought to you by Bristol Myers Squibb This program will share information about a treatment option for relapsed/refractory multiple myeloma including the impact of multiple myeloma on patients, dose modifications for consideration due to adverse events, and approaches to keep patients on therapy. 

Read more
SponsoredBlogPost_21

Treatment Options for the Management of Patients with 1L aRCC Theater Presentation

Brought to you by Bristol Myers Squibb You are cordially invited to join the Theater Presentation, Treatment Options for the Management of Patients with 1L aRCC, on Thursday, April 16th at 3:00 PM EST during the 46th Annual ONS Congress. Ann Lau Clark, RN, MSN, will present Treatment Options for the Management of Patients with 1L aRCC, that reviews […]

Read more
SponsoredBlogPost_21

Research to Practice Presents Dissecting the Decision: Investigator Perspectives on Key Issues in the Management of Common Cancers

Brought to you by Research to Practice Join Dr Neil Love and 29 invited clinical investigators for this unique 11-part NCPD-accredited series designed specifically for oncology nurses. prior to these sessions, Dr Love will be sitting down with nurses in clinical practice from across the country as they present challenging cases from their practices. These recorded conversations will […]

Read more
SponsoredBlogPost_21

CURE Media Group is Honoring Extraordinary Nurses for their Selflessness and Compassion in Patient Care

Brought to you by CURE Media Group CURE Media Group, the industry-leading multimedia platform devoted to cancer updates and research is celebrating outstanding nurses for their contributions to oncology care. This year’s Extraordinary Healer® Award for Oncology Nursing recognition event is taking place virtually on Thursday, April 29, from 6:30-8:00 p.m. EDT, in conjunction with the 46th Annual ONS Congress™.  Now in […]

Read more